Related Experiment Video
Updated: Jun 8, 2026

Magnetic Adjustment of Afterload in Engineered Heart Tissues
Published on: May 5, 2020
Management and Outcomes of Society for Cardiovascular Angiography and Interventions Stage B Cardiogenic Shock
Chirag Mehta1, Phinnara Has2, Aryan Mehta3,4
1Department of Medicine (C.M., I.V., B.O., A. Shin, V.C., S.C., D.D.P., A. Sweeting, R.T.), Warren Alpert Medical School of Brown University, Providence, RI.
Insights
A quarter of patients with Society for Cardiovascular Angiography and Interventions (SCAI) B cardiogenic shock deteriorated. Acute kidney injury and diuretic resistance predict worse outcomes in these patients.
Area of Science:
- Cardiology
- Critical Care Medicine
- Clinical Research
Background:
- Limited data exist on the etiology, management, and outcomes of Society for Cardiovascular Angiography and Interventions (SCAI) B cardiogenic shock.
- SCAI B cardiogenic shock is characterized by hypotension or hypoperfusion in adult patients.
Purpose of the Study:
- To evaluate the etiology, management, and outcomes of SCAI B cardiogenic shock.
- To identify predictors of clinical deterioration in patients with SCAI B cardiogenic shock.
Main Methods:
- A retrospective study of 500 adult patients with SCAI B cardiogenic shock from 2017-2022.
- Defined SCAI B cardiogenic shock as hypotension (systolic ≤90/mean ≤65 mm Hg) or hypoperfusion (lactate 2-5 mEq/L), excluding cardiac arrest and circulatory support.
- Used multivariable analysis and mixed-effects regression to identify predictors of a composite endpoint including transfer to higher care, SCAI stage escalation, or in-hospital mortality.
Main Results:
- The most common etiologies were heart failure (37%), arrhythmia (23%), and acute myocardial infarction (13%).
- A quarter of patients (135/500) experienced clinical deterioration.
- Independent predictors of deterioration included acute kidney injury (aOR 2.17) and diuretic resistance (aOR 9.55). Patients with isolated hypotension had worse outcomes than those with isolated hypoperfusion.
Conclusions:
- A quarter of patients with SCAI B cardiogenic shock experienced clinical deterioration.
- Acute kidney injury and diuretic resistance within 24 hours were independently predictive of clinical deterioration.
- These findings highlight key factors for monitoring and managing patients with SCAI B cardiogenic shock.
Background:
There are limited data on the etiology, management, and outcomes of Society for Cardiovascular Angiography and Interventions (SCAI) stage B cardiogenic shock.
Methods:
From 2017 to 2022, adult patients (≥18 years) admitted to the medical, intermediate, and critical care units in a 6-hospital system were evaluated. SCAI stage B cardiogenic shock was defined as hypotension (systolic ≤90/mean ≤65 mm Hg) or hypoperfusion (lactate 2-5 mEq/L). Cardiac arrest, use of circulatory support, and noncardiac etiologies were excluded. The composite primary end point included transfer to a higher level of care, SCAI stage escalation, or in-hospital mortality. Multivariable analysis and mixed-effects regression models were used.
Results:
During this period, 500 patients (median age, 76 years; 56% men; 79% White) developed SCAI stage B cardiogenic shock (hypotension 18%, hypoperfusion 82%). The most common etiologies were heart failure (37%), arrhythmia (23%), and acute myocardial infarction (13%). The primary composite end point was noted in 135 patients (deterioration cohort). The deterioration cohort had comparable baseline characteristics to those who recovered, but before the primary outcome, had lower blood pressures, higher rates of renal (60% versus 33%) and hepatic (15% versus 4%) injury, less negative fluid balance (-0.30 versus -0.68 L), and greater diuretic resistance (21% versus 2%; P<0.001). In a multivariable analysis, acute kidney injury-adjusted odds ratio 2.17 (95% CI, 1.11-4.22); P=0.02-and diuretic resistance-adjusted odds ratio 9.55 (95% CI, 2.61-34.89); P=0.001-were independently predictive of clinical deterioration. Patients with isolated hypotension had worse outcomes compared with those with isolated hypoperfusion.
Conclusions:
Among patients with SCAI stage B cardiogenic shock, a quarter of the population experienced clinical deterioration. Acute kidney injury and diuretic resistance in the preceding 24 hours were independently predictive of developing the primary end point.
More Related Videos
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure IV: Classification and Diagnostic Evaluation

